CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
0 hedge funds and large institutions have $0 invested in CUBIST PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 302 closing their positions.
100% less funds holding
Funds holding: 307 → 0 (-307)
100% less funds holding in top 10
Funds holding in top 10: 35 → 0 (-35)
100% less capital invested
Capital invested by funds: $8B → $0 (-$8B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 302
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$625M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$474M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$309M |
| 4 |
State Street
Boston,
Massachusetts
|
-$290M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$287M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
301
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1K | -9 | Closed |
|
CBST Hedge Fund Activity: Q1 2015 in Review
0 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2015, worth a combined $0 — down 100% from $8B a quarter earlier.
Sellers outnumbered buyers: 302 funds closed out of CBST and 0 opened new positions — a net loss of 302 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $625M sold.
- 0 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2015, down from 307 in Q4 2014.
- Funds reported $0 of CUBIST PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2015 and 302 closed out, a net change of -302 holders.
- The largest CUBIST PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $625M sold.
Based on aggregated 13F filings for Q1 2015.